bupranolol has been researched along with Neurotic Disorders in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "52 patients with acute neurotic anxious and psychosomatic syndromes or chronic anxious and vegetative neuroses were treated orally with the combination drug Betamed (1 tablet contain 60 mg bupranolol and 2." | 5.05 | [Betamed in the treatment of psychogenic disorders with a somatic component]. ( Jellinger, K, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jellinger, K | 1 |
1 trial available for bupranolol and Neurotic Disorders
| Article | Year |
|---|---|
[Betamed in the treatment of psychogenic disorders with a somatic component].
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupranolol; Clinical Trials as Topic; Diazepam; Drug Adm | 1983 |